Bibliographic citations
Villarreal, D., (2020). Sepsis neonatal precoz como factor de riesgo de displasia broncopulmonar: artículo de revisión [Tesis, Universidad Privada Antenor Orrego - UPAO]. https://hdl.handle.net/20.500.12759/6833
Villarreal, D., Sepsis neonatal precoz como factor de riesgo de displasia broncopulmonar: artículo de revisión [Tesis]. PE: Universidad Privada Antenor Orrego - UPAO; 2020. https://hdl.handle.net/20.500.12759/6833
@misc{renati/380709,
title = "Sepsis neonatal precoz como factor de riesgo de displasia broncopulmonar: artículo de revisión",
author = "Villarreal Castañeda, Daniela Isabel",
publisher = "Universidad Privada Antenor Orrego - UPAO",
year = "2020"
}
Neonatal sepsis constitutes the systemic inflammatory response due to infection within the first 28 days of life. Precocious neonatal sepsis is that which occurs during the first 7 days of life (some consider the first 72 hours) and is due to vertical transmission of pathogens located in the birth canal and intrauterine infections. The association between neonatal sepsis and bronchopulmonary dysplasia (BPD), a chronic pulmonary pathology in relation to alveolar injury due to mechanical ventilation and supplemental oxygen has been little investigated. Prematurity is the main risk factor and inflammation is the common pathogenic mechanism for both pathologies (BPD and neonatal sepsis). In the course of the last 10 years, the incidence of bronchopulmonary dysplasia has not decreased and with this, neither have its implications in the respiratory morbidity of the child; Given this, it is necessary to evaluate the available literature on these topics, looking for scientific evidence that allows establishing a connection between them. It has been shown that the presence of ureaplasma in the airways increases the risk of BPD, additionally neonatal sepsis (OR: 2.2 - 2.9) and late neonatal sepsis (OR: 1.64 - 2.17) have been suggested as factors of independent risk for the development of BPD; Neonatal sepsis has also been proposed as a risk factor for the severity of the symptoms (OR: 1.5). Despite this, the evidence is scarce and inconclusive, which is why prospective studies and meta-analyzes are required to provide conclusions with a higher level of evidence.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.